Breaking News Instant updates and real-time market news.

MGEN

Miragen Therapeutics

$6.40

-0.03 (-0.47%)

07:07
08/06/18
08/06
07:07
08/06/18
07:07

Miragen Therapeutics, LLS enter agreement to support development of cobomarsen

miRagen Therapeutics and The Leukemia & Lymphoma Society announced that they entered into an agreement providing for collaboration and funding intended to support the development of miRagen's cobomarsen, a microRNA-155 inhibitor, for the treatment of patients with the mycosis fungoides form of cutaneous T-cell lymphoma. There are approximately 16,000-20,000 people in the U.S. with mycosis fungoides. LLS will provide up to $5M through the purchase of miRagen common stock to help support the SOLAR trial. This includes a $1M investment upon signing of the agreement and potential additional stock purchases upon the achievement of certain milestones during the SOLAR trial. Funding from LLS is being provided under its Therapy Acceleration Program, a strategic initiative through which LLS partners directly with biotechnology companies and academic institutions to help accelerate the development of promising therapies. Additionally, LLS will continue to provide comprehensive patient support and education to MF patients to help them better understand their treatment options. Through LLS's Clinical Trial Support Center, specially trained nurses will help MF patients find and enroll in clinical trials based on highly detailed, individualized assessments.

  • 07

    Aug

  • 14

    Aug

MGEN Miragen Therapeutics
$6.40

-0.03 (-0.47%)

07/09/18
OPCO
07/09/18
NO CHANGE
Target $19
OPCO
Outperform
Miragen Therapeutics price target raised to $19 from $13 at Oppenheimer
Oppenheimer analyst Leah Rush Cann raised her price target fro Miragen Therapeutics to $19 from $13 to account for an increased average forward price-to-sales multiple of the biotechnology sector. The analyst reiterates an Outperform rating on the shares.
03/29/18
JEFF
03/29/18
INITIATION
Target $14
JEFF
Buy
Miragen Therapeutics initiated with a Buy at Jefferies
Jefferies analyst Eun Yang started Miragen Therapeutics with a Buy rating and $14 price target. The analyst believes the company has a leading position in microRNA therapy and thinks early clinical data could expand the "relatively inexpensive" valuation.
03/22/18
03/22/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Ultragenyx (RARE) assumed with an Overweight at Piper Jaffray. 2. Trivago (TRVG) was initiated with a Buy at Mizuho while TripAdvisor (TRIP) and Expedia (EXPE) were initiated with a Neutral. 3. Miragen Therapeutics (MGEN) initiated with a Buy at Deutsche Bank. 4. Arris (ARRS) assumed with an Equal Weight at Barclays. 5. Sientra (SIEN) initiated with a Buy at Maxim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/22/18
DBAB
03/22/18
INITIATION
Target $15
DBAB
Buy
Deutsche Bank views Miragen as undervalued, starts with Buy rating
Deutsche Bank analyst Andrew Peters initiated Miragen Therapeutics with a Buy rating and $15 price target. Early data for MRG-106 imply an active, safe, and well-tolerated compound, which positions the miR-155 antimiR well to capture a meaningful share of the systemic CTCL mycosis fungoides market, Peters tells investors in a research note. He sees a disconnect between these early data and the stock's current valuation. The analyst views Miragen as undervalued at current share levels.

TODAY'S FREE FLY STORIES

XYF

X Financial

$6.23

0.715 (12.98%)

17:23
03/18/19
03/18
17:23
03/18/19
17:23
Earnings
X Financial reports Q4 EPS 24c, two estimates 24c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

CADE

Cadence Bancorp

$20.24

0.51 (2.58%)

17:22
03/18/19
03/18
17:22
03/18/19
17:22
Hot Stocks
Cadence Bancorp President Samuel Tortorici buys almost $1M in company shares »

Cadence Bancorp President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

CELP

Cypress Energy

$7.41

0.06 (0.82%)

17:22
03/18/19
03/18
17:22
03/18/19
17:22
Syndicate
Breaking Syndicate news story on Cypress Energy »

Cypress Energy files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

JWN

Nordstrom

$44.21

0.465 (1.06%)

17:21
03/18/19
03/18
17:21
03/18/19
17:21
Syndicate
Breaking Syndicate news story on Nordstrom »

Nordstrom files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$171.73

2.13 (1.26%)

17:20
03/18/19
03/18
17:20
03/18/19
17:20
Hot Stocks
General Dynamics awarded $2.04B Navy submarine material contract modification »

General Dynamics has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

FFIN

First Financial

$61.60

0.44 (0.72%)

, MBFI

MB Financial

$47.20

0.63 (1.35%)

17:19
03/18/19
03/18
17:19
03/18/19
17:19
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

First Financial…

FFIN

First Financial

$61.60

0.44 (0.72%)

MBFI

MB Financial

$47.20

0.63 (1.35%)

FOE

Ferro

$18.88

0.125 (0.67%)

FITB

Fifth Third

$28.74

0.42 (1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 16

    Apr

  • 23

    Apr

  • 23

    Apr

FOE

Ferro

$18.88

0.125 (0.67%)

, FFIN

First Financial

$61.60

0.44 (0.72%)

17:17
03/18/19
03/18
17:17
03/18/19
17:17
Hot Stocks
Breaking Hot Stocks news story on Ferro, First Financial »

Ferro to replace First…

FOE

Ferro

$18.88

0.125 (0.67%)

FFIN

First Financial

$61.60

0.44 (0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

FFIN

First Financial

$61.60

0.44 (0.72%)

, MBFI

MB Financial

$47.20

0.63 (1.35%)

17:17
03/18/19
03/18
17:17
03/18/19
17:17
Hot Stocks
First Financial to replace MB Financial in S&P 400 at open on 3/22 »

Fifth Third Bancorp…

FFIN

First Financial

$61.60

0.44 (0.72%)

MBFI

MB Financial

$47.20

0.63 (1.35%)

FITB

Fifth Third

$28.74

0.42 (1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 16

    Apr

  • 23

    Apr

  • 23

    Apr

CUTR

Cutera

$18.00

-0.29 (-1.59%)

17:13
03/18/19
03/18
17:13
03/18/19
17:13
Hot Stocks
Cutera director Daniel Plants buys almost $1.5M in company shares »

Cutera director Daniel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

SMTX

SMTC Corp.

$4.41

-0.1 (-2.22%)

17:13
03/18/19
03/18
17:13
03/18/19
17:13
Syndicate
Breaking Syndicate news story on SMTC Corp. »

SMTC Corp. files $50M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 28

    May

SNE

Sony

$46.10

-0.16 (-0.35%)

, AAPL

Apple

$188.03

1.83 (0.98%)

17:09
03/18/19
03/18
17:09
03/18/19
17:09
Periodicals
PlayStation Vue now lets Apple TV users watch four channels at once, Verge says »

According to the…

SNE

Sony

$46.10

-0.16 (-0.35%)

AAPL

Apple

$188.03

1.83 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRRM

Verra Mobility

$10.89

0.15 (1.40%)

17:08
03/18/19
03/18
17:08
03/18/19
17:08
Earnings
Verra Mobility reports Q4 net ($38.0M) vs. ($29.2M) last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

EQH

AXA Equitable

$20.86

0.09 (0.43%)

17:06
03/18/19
03/18
17:06
03/18/19
17:06
Syndicate
AXA Equitable files to sell 40M shares of common stock for holders »

In connection with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$113.07

-1.89 (-1.64%)

17:04
03/18/19
03/18
17:04
03/18/19
17:04
Hot Stocks
ESPN+ to become exclusive distributor of UFC Pay-Per-View events »

UFC and ESPN+ announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Apr

STML

Stemline

$12.92

-0.71 (-5.21%)

17:02
03/18/19
03/18
17:02
03/18/19
17:02
Recommendations
Stemline analyst commentary at Piper Jaffray »

Stemline sees positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REV

Revlon

$19.39

0.42 (2.21%)

17:02
03/18/19
03/18
17:02
03/18/19
17:02
Hot Stocks
Revlon down 15% after Q4 results miss estimates »

The company also…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

ATR

AptarGroup

$103.69

0.75 (0.73%)

17:01
03/18/19
03/18
17:01
03/18/19
17:01
Hot Stocks
AptarGroup's Bidose approved by FDA for breakthrough treatment of depression »

Aptar Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 01

    May

  • 01

    May

XELA

Exela Technologies

$3.82

-0.03 (-0.78%)

16:57
03/18/19
03/18
16:57
03/18/19
16:57
Earnings
Exela Technologies sees FY19 revenue $1.66B-$1.7B, consensus $1.68B »

Sees FY19 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

XELA

Exela Technologies

$3.82

-0.03 (-0.78%)

16:56
03/18/19
03/18
16:56
03/18/19
16:56
Earnings
Exela Technologies reports Q4 revenue $399.6M, consensus $401.4M »

Reports Q4 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

BIO

Bio-Rad

$313.64

3.58 (1.15%)

16:55
03/18/19
03/18
16:55
03/18/19
16:55
Hot Stocks
Bio-Rad extends 10-K filing by 15 days to complete year-end procedures »

In a regulatory 8-K…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AERI

Aerie Pharmaceuticals

$47.09

0.09 (0.19%)

16:55
03/18/19
03/18
16:55
03/18/19
16:55
Conference/Events
Aerie Pharmaceuticals management to meet with JMP Securities »

Group Dinner Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 19

    Mar

  • 08

    Apr

NOMD

Nomad Foods

$21.45

-0.07 (-0.33%)

16:54
03/18/19
03/18
16:54
03/18/19
16:54
Syndicate
Nomad Foods files to sell 20M ordinary shares »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIS

FIS

$108.14

-0.73 (-0.67%)

, WP

Worldpay

$108.52

9.8 (9.93%)

16:54
03/18/19
03/18
16:54
03/18/19
16:54
Conference/Events
FIS management to meet with Wolfe Research »

Senior Payments & IT…

FIS

FIS

$108.14

-0.73 (-0.67%)

WP

Worldpay

$108.52

9.8 (9.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 18

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 04

    Apr

ORN

Orion Group

$4.23

0.145 (3.55%)

16:52
03/18/19
03/18
16:52
03/18/19
16:52
Hot Stocks
Orion Group delays filing of Form 10-K »

Orion Group Holdings said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

YEXT

Yext

$23.00

0.33 (1.46%)

16:50
03/18/19
03/18
16:50
03/18/19
16:50
Syndicate
Yext files to sell 6.1M shares of common stock »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.